瑞兴医药 (835553.OC)

+ 收藏

利润表(瑞兴医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年三季报2023年中报2022年年报2022年三季报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 71,168,636.29150,758,427.8298,033,275.3666,301,489.54223,844,088.34140,774,499.0183,430,098.65
 营业收入(元) 71,168,636.29150,758,427.8298,033,275.3666,301,489.54223,844,088.34140,774,499.0183,430,098.65
二、营业总成本(元) 70,333,655.00148,347,140.9995,047,549.8263,934,067.53214,641,595.50125,059,154.5475,270,831.82
 营业成本(元) 55,551,929.70119,966,299.3777,799,084.6053,300,036.40187,563,267.93109,790,577.2967,266,298.96
 研发费用(元) 2,798,023.281,175,015.87-----
 营业税金及附加(元) 492,080.831,858,073.93570,930.70381,901.842,061,589.64509,194.80368,226.16
 销售费用(元) 4,067,560.376,779,560.454,690,819.182,671,341.697,902,088.484,792,296.142,910,730.09
 管理费用(元) 5,556,583.2914,351,169.139,783,051.196,365,379.0012,605,697.117,598,669.093,245,232.20
 财务费用(元) 1,867,477.534,217,022.242,203,664.151,215,408.604,508,952.342,368,417.221,480,344.41
  其中:利息费用(元) 1,988,315.144,493,512.36-1,460,816.814,733,523.81-1,458,671.92
  其中:利息收入(元) -25,461.80292,195.62-243,721.45304,133.95-217,936.20
三、其他经营收益
 加:公允价值变动收益(元) -65,857.02-----
 加:投资收益(元) -118,774.08577,683.93-30,052.12-461,380.00-189,674.46-1,553,576.0532,941.57
  其中:对联营企业和合营企业的投资收益(元) -208,859.42519,649.85-----
 资产处置收益(元) -8,160.54-----
 资产减值损失(元) --100,848.73---20,846.76--
 信用减值损失(元) -79,963.82-691,820.10-1,016,432.4896,905.68-910,245.97-340,521.34-334,153.19
 其他收益(元) -3,387.61-----
四、营业利润(元) 636,243.392,273,707.101,939,240.942,002,947.698,081,725.6513,821,247.087,858,055.21
 加:营业外收入(元) 4,091.5744,034.0055,582.1515,582.151,750.27750.27-
 减:营业外支出(元) 102,000.0059,313.3950,866.5650,866.561,959.99196.03-
五、利润总额(元) 538,334.962,258,427.711,943,956.531,967,663.288,081,515.9313,821,801.327,858,055.21
 减:所得税费用(元) 279,173.011,688,442.90249,481.01557,253.663,502,450.174,549,861.192,809,305.35
六、净利润(元) 259,161.95569,984.811,694,475.521,410,409.624,579,065.769,271,940.135,048,749.86
(一)按经营持续性分类
  持续经营净利润(元) 259,161.95569,984.811,694,475.521,410,409.624,579,065.76-5,048,749.86
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 259,161.95569,984.811,694,475.521,410,409.624,579,065.769,271,940.135,048,749.86
 扣除非经常性损益后的净利润(元) 332,593.44475,596.06-1,393,729.044,553,695.68-5,048,749.86
七、每股收益
 一、基本每股收益(元) -0.010.020.020.080.090.09
 二、稀释每股收益(元) -0.010.020.020.080.090.09
九、综合收益总额(元) 259,161.95569,984.811,694,475.521,410,409.624,579,065.769,271,940.135,048,749.86
 归属于母公司所有者的综合收益总额(元) 259,161.95569,984.811,694,475.521,410,409.624,579,065.769,271,940.135,048,749.86
公告日期 2024-08-202024-04-262023-12-082023-08-152023-04-252022-11-162022-07-22
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院